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Introduction
It is well stated that psoriasis is an inflammatory skin disease in which both innate and adaptive immune activation play an essential role in the maintenance of the abnormal skin phenotype 1 . However, it is less known how much resident cells of the tissue contribute to the pathology. A reasonable approach to seek for alterations in tissue responses in psoriasis is to investigate the phenotypically normal looking non-lesional (NL) psoriatic skin. The main fibronectin receptor α 5 β 1 integrin was found to be overexpressed in the NL psoriatic epidermis relative to normal 2,3 . There is evidence that proper regulation of integrin expression in keratinocytes is essential for normal epidermal homeostasis as shown by the suprabasal overexpression of integrins in transgenic mice resulting in epidermal hyperproliferation and inflammatory reaction 4 . In the steady state of normal human adult epidermis α 5 integrin expression of keratinocytes is downregulated. A possible explanation of α 5 integrin overexpression in NL skin is the presence of fibronectin (FN) and one of its isoforms, the extra-domain-A containing fibronectin (EDA + FN), in the microenvironment of basal keratinocytes 3,5 . Keratinocyte growth factor (KGF/FGF7) is a member of the fibroblast growth factor (FGF) family produced by mesenchymal cells and considered to be a major growth factor for keratinocytes. Several reports suggest that KGF reduces the ability of keratinocytes to initiate terminal differentiation and undergo programmed cell death.
Overexpression of KGF in the basal epidermal cell layer of transgenic mice results in epidermal hyperplasia 6 . There is also evidence suggesting that fibroblasts from L and NL skin of psoriatic patients induce keratinocyte outgrowth by producing soluble signals 7 . More recently, it has been reported that KGF can induce the expression of α 5 integrin and delays the expression of keratin 10 and transglutaminase in keratinocytes 8 . Indirect evidence, such as measurement of mitogenic activity, suggests that the specific receptor for KGF on epithelial cells is the IIIb splice variant of fibroblast growth factor receptor 2 (FGFR2) 9 .
According to our observations, psoriatic NL skin displays a marked overexpression of KGF, FGFR2, α 5 integrin and EDA + FN compared to healthy skin, therefore in this study we focused on investigating regulatory mechanisms involving KGF and fibronectin. Our results revealed that KGF regulate EDA + FN production in an autocrine manner through MAPK signaling in healthy fibroblasts. With these results we designed an in silico model to predict a possible regulatory network for the effect of KGF on EDA + FN production. We provide in vitro evidence that both FN and EDA + FN are negatively regulated by activated STAT1 in healthy fibroblasts, and this is in contrast to psoriatic NL skin-derived fibroblasts. Active, phosphorylated STAT1 was found in healthy skin as well as in psoriatic lesions, but not in psoriatic NL skin, suggesting a crucial mechanism for keeping NL skin in a preactivated state for developing a chronic wound healing phenotype.
Materials and methods

Skin biopsies
Patients with moderate-to-severe chronic plaque type psoriasis and healthy volunteers (age 18-60 years) were enrolled into the study. Patients had a medication-free period of at least 4 weeks of systemic and/or at least 2 weeks without local therapy. Participant informed consent was obtained prior surgical intervention. PASI score was determined for all patients by dermatologists. Samples were collected from 16 patients and 25 healthy volunteers for the experiments. Mechanical stress was induced by tape stripping procedure, and then punch biopsies were taken from uninvolved skin of psoriatic patients (n=6) and from healthy (n=6) subjects from tape stripped and non-treated (control) skin area from the buttock area at 24 and 48 hours after treatment (supplementary figure 1 ) for all other experiments tissues without the introduction of mechanical stress were used. All tissue collection complied with the Guidelines of the Helsinki Declaration and was approved by the Regional and Institutional
Research Ethics Committee (2799, 3517).
Immunofluorescent staining
Human punch biopsies were frozen embedded, stored at -80 °C, then cut into 6 µm sections. Immunofluorescent staining revealed a striking difference in all protein expressions examined even without tape stripping between normal and psoriatic non-lesional skin ( 
Expression of FGFR2 splice variants in fibroblasts, melanocytes and keratinocytes
Two splice variants have been identified for FGFR2 designated as FGFR2-IIIb and FGFR2-
IIIc that have different ligand binding preferences. These result were based on mitotic activity measurements 16 . KGF has been shown to act on the FGFR2-IIIb variant increasing cellular proliferation 17 . We determined the expression of the splice variants on healthy fibroblasts, melanocytes and keratinocytes using specific primers designed for RT-PCR, revealing that melanocytes and keratinocytes expressed the FGFR2-IIIb only, while fibroblasts mainly expressed the FGFR2-IIIc variant (Fig. 3a, b) .
MAPK signaling is involved in the regulation of EDA + FN by KGF in healthy fibroblasts
FGF signals (including KGF) are coordinated by four major pathways: the RAS-RAF-MAPK, the PI3-AKT, the STAT and the PLCγ signaling 18, 19 . In order to get a better insight into the did not influence KGF-mediated changes in EDA + FN levels ( Fig. 4b) , however, impairing these signaling molecules resulted in a KGF independent elevation of both FN and EDA + FN protein levels that was significant in the case of STAT1 inhibition (Fig. 4c ).
Abnormal STAT1 activation in psoriatic skin plays a role in the regulation of both FN and EDA + FN
To investigate further, we compared the FN and EDA + FN expressions between healthy and psoriatic NL skin derived fibroblasts 24 hours after STAT1 or STAT3 inhibition in culture.
Changes upon STAT3 impairment were not significant, however, blockade of STAT1 did not lead to the elevation of total FN and the EDA + FN splice variant in fibroblasts from NL skin in contrast to healthy controls (Fig. 4c) . Therefore, we investigated the phosphorylation pattern of STAT1 at Tyr701 and Ser727 positions that are known to be key amino acid modifications leading to dimerization and influencing activity. Immunofluorescent staining for the phosphorylated Ser727 was highest in lesional psoriatic skin, lower, but clearly detectable in healthy skin whereas NL skin samples showed the lowest intensity. In two out of four investigated NL samples phosphorylation was undetectable (Fig. 4d) . Staining for the phosphorylated Tyr701 showed a much less noticeable but similar pattern. In samples of patients where no serine phosphorylation was detected in the NL skin, the staining for the phosphorylated Tyr701 was also not visible in either NL or L areas. To elucidate whether differences observed in STAT1 activity among patients correlated with the severity of the disease, PASI scores of donor patients were compared. The patients whose NL skin was negative for phosphorylations of STAT1 had a lower PASI score (12.4 and 17.8), therefore we were able to take NL samples further away from lesions at least 10 cm distance whereas patients with detectable, but low STAT1 activity in NL skin had a higher PASI score (19.6 and 20).
In silico model construction
We constructed an in silico model based on our in vitro results involving KGF-and FNsignaling and the resultant transcriptional regulation network (Fig. 5 , Table S1 -2). Our data already suggested the participation of MAPK signaling in KGF induced fibronectin splicing.
The generated co-expression matrix implied a potential role of peptidyl-prolyl cis-trans 
Discussion
One of the major characteristics of psoriatic lesional skin is the hyperproliferation of keratinocytes, where KGF is known to play an important role. At the protein level both KGF and FGFR2 were demonstrated to be elevated in lesional skin compared to normal skin 21 . At the mRNA level in non-lesional as well as in lesional tissue an increased expression for both KGF and FGFR2 transcripts were also described by others 21, 22 . STAT1 is the founding member of the STAT (signal transducer and activator of transcription) family and it is activated by interferons (IFNs), and signaling from IL-27, IL-35 and TLRs 44 .
There is ample evidence implicating IFNγ in the pathomechanism of psoriasis 45 . Aberrant signaling and transcription have been reported for psoriatic keratinocytes with regard to SOCS1, a negative regulator of IFNγ signaling 46 , and also for STAT1 and IRF-1 (interferon regulated factor 1) 47 . The complex role of STAT1 in immune regulation is apparent from animal studies showing that both STAT1 -/-and IFNγ -/-mice are highly susceptible to experimental autoimmune encephalomyelitis (EAE) 48, 49 . It has been demonstrated that in both multiple sclerosis (MS) and in the EAE model α5 integrin and FN could be responsible for the extensive vascular remodelling, characteristic for MS, that takes place during the presymptomatic phase in EAE 50 . The regulatory connection between STAT1 and FN described in this paper may explain the more severe disease manifestation in STAT -/-animals.
STAT1 has diverse functions, it inhibits certain genes and it is a functional transcription factor even in the absence of inducer-mediated activation. Among its major targets of negative regulation are genes encoding proteins involved in regulating the extracellular matrix: matrix metalloproteinases (MMPs), perlecan, bullosus phemphigoid antigen-1 (BPAG1) 51 . The cell suspensions were filtered through a 100 µm nylon mesh (BD Falcon, San Jose, CA, USA) and pelleted by centrifugation.
Fibroblasts were grown in low glucose DMEM medium containing 5% FBS. Melanocytes were maintained in Mel-mix medium as previously described 10 . Keratinocytes were grown in keratinocyte serum-free medium (Gibco® Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark). HaCaT cells were kindly provided by Prof N.E. Fusenig and cultured in high-glucose DMEM medium containing 10% FBS. All media was supplemented with 1%
antibiotic/antimycotic (PAA) and 1% L-glutamine solution (PAA). Fibroblasts, keratinocytes, melanocytes, and HaCaT cells were cultured at 37°C and 5% CO 2 in humidified conditions.
Depending on the cell growth, the medium was changed every 2-4 days and cells were passaged at 80% confluence. In our experiments, fibroblasts at passage number 5, keratinocytes and melanocytes at passage 3 were used at 70% confluence.
Fibroblasts, keratinocytes and HaCaT cells were cultured in 6-well plates at a starting density of 200,000 cells/well and incubated with 25 ng/mL KGF (ProSpec -Tany TechnoGene Ltd., Rehovot, Israel) for 24 h; untreated cells were used as controls. For KGF signaling pathway blocking experiments the following inhibitors were used: MEK1 inhibitor (PD98059, 20µM), Akt ½ kinase inhibitor (10µM), STAT1 inhibitor (Epigallocatechin gallate, 40µM) and STAT3 inhibitor (Stattic, 4µM), all provided by Sigma-Aldrich, concentrations were applied as previously described [11] [12] [13] .
RNA extraction and real-time quantitative reverse transcription polymerase chain reaction (RT qRT-PCR)
For RNA isolation fibroblasts, melanocytes and keratinocytes were cultured as described above. Cells on 6 well plates were washed once with PBS, then harvested with 0.5 ml for the assessment of the direction of transcriptional regulation. If correlation coefficient was positive it was considered an upregulation, and if it was negative, down regulation was defined.
